PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 1, 2004Diabetes Technology & Therapeutics49 citations

Volatile Metabolic Monitoring of Glycemic Status in Diabetes Using Electronic Olfaction

View Full Paper
PDPamela DaltonAGAlan GelperinGPGeorge Preti

Key Points

Key points are not available for this paper at this time.

Abstract

The increased incidence of Type I and Type II diabetes among adults and adolescents is a growing public health concern worldwide. The primary objective of diabetes mellitus management involves keeping glycemia levels within the euglycemic range to prevent a variety of serious health complications. Unfortunately, daily self-monitoring is both a requirement and a problem for many patients with diabetes, particularly children and adolescents. Studies have shown that as many as 43% of adolescents and 30% of children (<14 years old) regularly forget to use glycemic tests and are significantly poorer at recognizing and reporting symptoms and signs of hypoglycemia/hyperglycemia. For this reason, methods for noninvasive, continuous monitoring that can signal glycemic status to a parent, teacher, or other caregiver would improve the care and management of symptoms of diabetes among these individuals. The goal of this review is to describe and evaluate electronic olfaction technology ("electronic nose") for monitoring the presence and levels of volatile chemicals from human body and breath that can be used to evaluate status of diabetes. The review is organized in four sections. The first section reviews the chemistry of the volatile signals that are produced by the body that are indicative of metabolic status. The second section provides an overview of novel sensor technology, e.g., "electronic olfaction," that mimics the biological olfactory system and can be used to monitor and identify complex plumes of volatiles that are signatures of metabolic states. The third section reviews studies that have employed electronic "nose" technology for diagnosis and monitoring of diabetes via urine and breath, and the final section discusses needed future directions for the development of olfactory-based metabolic monitoring, particularly among noncompliant populations.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Dalton et al. (2004) studied this question.

synapsesocial.com/papers/6a2031c045d96add4db5c86ehttps://doi.org/10.1089/1520915041705992
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes2004 · 2,196 citations
  2. 2Analysis of human axillary volatiles: compounds of exogenous origin1979 · 41 citations
  3. 3Classification of bacteria responsible for ENT and eye infections using the Cyranose system2002 · 60 citations
  4. 4Monitoring wound healing by odour1997 · 34 citations
  5. 5Nanotube Molecular Wires as Chemical Sensors2000 · 6,038 citations